SlideShare a Scribd company logo
By
DR MONKEZ M YOUSIF
Professor of Internal Medicine
Zagazig University
2012
Anticoagulation
part 1 (Thrombophilia)
Objectives
• Physiology of coagulation
• Thrombophilia (Hypercoagulation states)
• Venous thromboembolism
• Anticoagulants
• Case studies
Definition of thrombophilia
A disorder associated with an
increased tendency to thrombosis.
VESSEL WALL
ENDOTHEL
PLATELETS
PLASMA
FACTORS
(procoagulation,
anti-coagulation)
HEMOSTASIS = the arrest of bleeding
from an injured vessel
Hemostatic abnormalities can result in procoagulation or/and anti-coagulation
conditions
The Role of Platelets in Hemostasis
Collagen Other
factorsTF
Thrombin
Activated
platelet
Activated
platelet
Activated
platelet
Adhesion
Aggregation
Contraction
Secretion
Primary
Hemostasis
=
Activated
platelet
Activated
platelet
Activated
platelet
Activated
platelet
This plug of activated platelets, localised to the site of injury, provides the
phospholipid surface upon which Secondary Hemostasis takes place
Coagulation Cascade
XII XIIa
XI XIa
IX
VIII VIIIa
X
Xa
Intrinsic Pathway Extrinsic Pathway
Endothelial activation or
exposure of subendothelium
Tissue Factor
VIITF/VIIa
Kallikrein
HMWK
Prekallikrein
IIaII
Ca2+
PL
Va V
Organized
Fibrin/Platelet
thrombus
Fibrinogen
Fibrin
Ca2+
PLCa2+
Cross-linked
fibrin polymer
XIIIa
Ca2+
IXa
Fibrinolysis
Coagulation Cascade:
Regulation
• Antithrombin (III)
– Regulates activity of all serine proteases
– Inhibitory activity enhanced by heparin
• Protein C and Protein S
– Regulate the activity of co-factors of coagulation
Va/VIIIa
The Cell-based Model of Coagulation
VIIIa
IXa
+ activates various
factors
APC/PS
TFPI
Antithrombin
What is a Thrombus?
Intravascular mass of fibrin and blood cells
Arterial thrombi (White thrombi)
– High shear rates
– Primarily platelet aggregates + fibrin strands
Venous Thrombi (Red thrombi)
– Low shear rates
– Primarily red cells and fibrin strands (few
platelets)
LDL
LDL
Mackness MI et al. Biochem J 1993;294:829-834.
Endothelium
Vessel LumenMonocyte
Modified LDL
Macrophage
MCP-1
Adhesion
Molecules
Cytokines
Pathophysiology of Atherosclerosis
Foam
Cell
HDL Promote Cholesterol Efflux
Intima
HDL Inhibit
Oxidation
of LDL
Virchow’s thrombosis
model
Thrombosis
Vessel wall
injury
Slow blood
flow (Stasis)
Hypercoagulability
Injury or Activation of
Endothelium
• Atherosclerosis
– Life style - smoking, obesity
• Immune mediated
– Heparin induced thrombocytopenia
– Antiphospholipid Antibody Syndrome (Lupus
Inhib)
• Trauma
• Artificial Surface (vascular graft)
• Inflammation/Infection
Abnormal Blood Flow
 Decreased mobility
 Vessel Obstruction
 Eccomomy class syndrome
 Pregnancy
Risk Factors for Venous Thrombosis
Acquired
Pregnancy
Advancing age
Prior thrombosis
Immobilization
Major surgery
Malignancy
Estrogens (OCP, HRT< SERMs)
APA syndrome
Myeloproliferative disorders, IBD
HIT
Prolonged air travel
Inherited
Antithrombin
Deficiency
Protein C deficiency
Protein S deficiency
Factor V Leiden (FVL)
Prothrombin G20210A
Dysfibrinogenemias
(rare)
Mixed/Unknown
Homocysteine
Factor VIII, IX, XI
APC resistance in the
absence of FVL
Free TFPI
PAI-I, PAI-II
Site of Thrombosis vs. Coag. Defect
Abnormality Arterial Venous
Factor V Leiden - +
Prothrombin G20210A - +
Antithrombin deficiency - +
Protein C deficiency - +
Protein S deficiency - +
Hyperhomocysteinemia + +
Lupus Anticoagulant + +
Type I (non immune mediated)
 The more common form,
 May occur in up to 15% of patients receiving
therapeutic doses of heparin
 Benign and self limiting side effect.
 Rarely causes severe thrombocytopenia
 Usually doesn't require heparin discontinuation.
Heparin induced thrombocytopenia
(HIT)
Type II (immune type of HIT)
Pathogenesis involves the formation of antibodies
(usually IgG) against the heparin-platelet factor 4
(PF 4) complex. The HIT Abs trigger procoagulant
effect serious arterial and venous
thrombosis
J Thromb Haem 1,1471, 2003
The incidence of HIT is about 3-5% in
patients exposed to UFH, the incidence is
much lower with the use of LMWH.
In patients with de novo exposure to heparin a
fall in the platelet count in those with HIT
occurs between day 5 and 14.
Suspicion
• Fall in platelet count by 50% following heparin
exposure
The clinical spectrum
• Isolated HIT
• HIT (T), that may be arterial (Stroke, MI, PAD)
or venous in nature.
Lab diagnosis
• Functional assays
---heparin induced platelet aggregation,
---serotonin release assay,
• Immunoassays
---Ab to heparin-PF 4 complexes.
Treatment
Stopping Heparin and
Direct thrombin inhibitors Argatorban
Platelet transfusion should be avoided
Once the platelet count is > 100.000/CC warfarin may be
started at low dose.
Bilateral foot ischemia secondary to HIT post open heart surgery
Bilateral foot ischemia secondary to HIT post open heart surgery
Arm ischemia secondary to HIT post open heart surgery
Anticoagulation  part 1 (thrombophilia)

More Related Content

What's hot

Thrombotic disorders
Thrombotic disordersThrombotic disorders
Thrombotic disorders
Somu Venkatesh
 
Bleeding & clotting disorders
Bleeding & clotting disordersBleeding & clotting disorders
Bleeding & clotting disordersshabeel pn
 
Coagulation disorder
Coagulation disorder Coagulation disorder
Coagulation disorder
AHLAM MAJALI
 
Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
DR. JITHIN GEORGE
 
Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders
Rakesh Verma
 
Bernard soulier syndrome
Bernard soulier syndromeBernard soulier syndrome
Bernard soulier syndrome
Shahin Hameed
 
Glannzmann Thromboasthenia
Glannzmann ThromboastheniaGlannzmann Thromboasthenia
Glannzmann Thromboasthenia
jayatheeswaranvijayakumar
 
V. Hyper Coagulation State
V. Hyper Coagulation StateV. Hyper Coagulation State
V. Hyper Coagulation State
najmaldin saki
 
Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)student
 
Glanzmann thrombasthenia
Glanzmann thrombastheniaGlanzmann thrombasthenia
Glanzmann thrombasthenia
vijay dihora
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)student
 
Disorders of Platelets
Disorders of PlateletsDisorders of Platelets
Disorders of Platelets
Dr. Juan Carlos Becerra Martinez
 
Plt disorders 2015
Plt disorders 2015Plt disorders 2015
Plt disorders 2015
katejohnpunag
 
TTP.ppt
TTP.pptTTP.ppt
Congenital bleeding disorders
Congenital bleeding disordersCongenital bleeding disorders
Congenital bleeding disorders
Mia Lesaca-Medina
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Dr. SHEETAL KAPSE
 
Approach to a bleeding child
Approach to a bleeding childApproach to a bleeding child
Approach to a bleeding child
Dr Jishnu KR
 
Coagulopathy
CoagulopathyCoagulopathy
Coagulopathy
Labib Mortuza
 
evaluation of thrombocytopenia
evaluation of thrombocytopeniaevaluation of thrombocytopenia
evaluation of thrombocytopenia
Jhysheng Chang
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia

What's hot (20)

Thrombotic disorders
Thrombotic disordersThrombotic disorders
Thrombotic disorders
 
Bleeding & clotting disorders
Bleeding & clotting disordersBleeding & clotting disorders
Bleeding & clotting disorders
 
Coagulation disorder
Coagulation disorder Coagulation disorder
Coagulation disorder
 
Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
 
Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders
 
Bernard soulier syndrome
Bernard soulier syndromeBernard soulier syndrome
Bernard soulier syndrome
 
Glannzmann Thromboasthenia
Glannzmann ThromboastheniaGlannzmann Thromboasthenia
Glannzmann Thromboasthenia
 
V. Hyper Coagulation State
V. Hyper Coagulation StateV. Hyper Coagulation State
V. Hyper Coagulation State
 
Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)
 
Glanzmann thrombasthenia
Glanzmann thrombastheniaGlanzmann thrombasthenia
Glanzmann thrombasthenia
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
 
Disorders of Platelets
Disorders of PlateletsDisorders of Platelets
Disorders of Platelets
 
Plt disorders 2015
Plt disorders 2015Plt disorders 2015
Plt disorders 2015
 
TTP.ppt
TTP.pptTTP.ppt
TTP.ppt
 
Congenital bleeding disorders
Congenital bleeding disordersCongenital bleeding disorders
Congenital bleeding disorders
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Approach to a bleeding child
Approach to a bleeding childApproach to a bleeding child
Approach to a bleeding child
 
Coagulopathy
CoagulopathyCoagulopathy
Coagulopathy
 
evaluation of thrombocytopenia
evaluation of thrombocytopeniaevaluation of thrombocytopenia
evaluation of thrombocytopenia
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 

Similar to Anticoagulation part 1 (thrombophilia)

An approach to a patient with Thrombocytopenia
An approach to a patient with ThrombocytopeniaAn approach to a patient with Thrombocytopenia
An approach to a patient with Thrombocytopeniaaminanurnova
 
07 C.disorders.pptx
07 C.disorders.pptx07 C.disorders.pptx
07 C.disorders.pptx
AmosiRichard
 
Approach to patient with platelet disorders
Approach to patient with platelet disordersApproach to patient with platelet disorders
Approach to patient with platelet disorders
Chetan Ganteppanavar
 
BLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptxBLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptx
EidleMohamedsaed
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
Rajesh S
 
hemodynamic dsrdrs (2nd part).pptx
hemodynamic dsrdrs (2nd part).pptxhemodynamic dsrdrs (2nd part).pptx
hemodynamic dsrdrs (2nd part).pptx
spongybob1
 
Approach to Bleeding Patient.pptx
Approach to Bleeding Patient.pptxApproach to Bleeding Patient.pptx
Approach to Bleeding Patient.pptx
MongieEsihleZangwa
 
Short talk on hemophilia
Short talk on hemophiliaShort talk on hemophilia
Short talk on hemophilia
Hemant Pippal
 
platelets disorders
platelets disordersplatelets disorders
Coagulation dirorder 2021
Coagulation dirorder 2021Coagulation dirorder 2021
Coagulation dirorder 2021
aljamhori teaching hospital
 
4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx
MohammadKhan656704
 
The hypercoagulable states in anaesthesia
The hypercoagulable states in anaesthesiaThe hypercoagulable states in anaesthesia
The hypercoagulable states in anaesthesia
Siddhanta Choudhury
 
Hemorrhagic Syndromes
Hemorrhagic SyndromesHemorrhagic Syndromes
Hemorrhagic Syndromes
Shubham Patil
 
Bleeding disorders in pregnancy
Bleeding disorders in pregnancyBleeding disorders in pregnancy
Bleeding disorders in pregnancydrmcbansal
 
Factor v deficiency
Factor v deficiencyFactor v deficiency
Factor v deficiency
LeenDoya
 
Approach to the adult with bleeding disorder
Approach to the adult with bleeding disorderApproach to the adult with bleeding disorder
Approach to the adult with bleeding disorder
Ali S. Mayali
 
thromboticdisorders-150818135124-lva1-app6892.pdf
thromboticdisorders-150818135124-lva1-app6892.pdfthromboticdisorders-150818135124-lva1-app6892.pdf
thromboticdisorders-150818135124-lva1-app6892.pdf
mergawekwaya
 
Anticoagulants and thrombolytic drugs.ppt
Anticoagulants and thrombolytic drugs.pptAnticoagulants and thrombolytic drugs.ppt
Anticoagulants and thrombolytic drugs.ppt
EdwinMoguche1
 

Similar to Anticoagulation part 1 (thrombophilia) (20)

An approach to a patient with Thrombocytopenia
An approach to a patient with ThrombocytopeniaAn approach to a patient with Thrombocytopenia
An approach to a patient with Thrombocytopenia
 
07 C.disorders.pptx
07 C.disorders.pptx07 C.disorders.pptx
07 C.disorders.pptx
 
Hemostasis
HemostasisHemostasis
Hemostasis
 
Approach to patient with platelet disorders
Approach to patient with platelet disordersApproach to patient with platelet disorders
Approach to patient with platelet disorders
 
BLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptxBLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptx
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
 
hemodynamic dsrdrs (2nd part).pptx
hemodynamic dsrdrs (2nd part).pptxhemodynamic dsrdrs (2nd part).pptx
hemodynamic dsrdrs (2nd part).pptx
 
Approach to Bleeding Patient.pptx
Approach to Bleeding Patient.pptxApproach to Bleeding Patient.pptx
Approach to Bleeding Patient.pptx
 
Platelet
PlateletPlatelet
Platelet
 
Short talk on hemophilia
Short talk on hemophiliaShort talk on hemophilia
Short talk on hemophilia
 
platelets disorders
platelets disordersplatelets disorders
platelets disorders
 
Coagulation dirorder 2021
Coagulation dirorder 2021Coagulation dirorder 2021
Coagulation dirorder 2021
 
4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx
 
The hypercoagulable states in anaesthesia
The hypercoagulable states in anaesthesiaThe hypercoagulable states in anaesthesia
The hypercoagulable states in anaesthesia
 
Hemorrhagic Syndromes
Hemorrhagic SyndromesHemorrhagic Syndromes
Hemorrhagic Syndromes
 
Bleeding disorders in pregnancy
Bleeding disorders in pregnancyBleeding disorders in pregnancy
Bleeding disorders in pregnancy
 
Factor v deficiency
Factor v deficiencyFactor v deficiency
Factor v deficiency
 
Approach to the adult with bleeding disorder
Approach to the adult with bleeding disorderApproach to the adult with bleeding disorder
Approach to the adult with bleeding disorder
 
thromboticdisorders-150818135124-lva1-app6892.pdf
thromboticdisorders-150818135124-lva1-app6892.pdfthromboticdisorders-150818135124-lva1-app6892.pdf
thromboticdisorders-150818135124-lva1-app6892.pdf
 
Anticoagulants and thrombolytic drugs.ppt
Anticoagulants and thrombolytic drugs.pptAnticoagulants and thrombolytic drugs.ppt
Anticoagulants and thrombolytic drugs.ppt
 

Recently uploaded

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

Anticoagulation part 1 (thrombophilia)

  • 1. By DR MONKEZ M YOUSIF Professor of Internal Medicine Zagazig University 2012 Anticoagulation part 1 (Thrombophilia)
  • 2. Objectives • Physiology of coagulation • Thrombophilia (Hypercoagulation states) • Venous thromboembolism • Anticoagulants • Case studies
  • 3. Definition of thrombophilia A disorder associated with an increased tendency to thrombosis.
  • 4.
  • 5. VESSEL WALL ENDOTHEL PLATELETS PLASMA FACTORS (procoagulation, anti-coagulation) HEMOSTASIS = the arrest of bleeding from an injured vessel Hemostatic abnormalities can result in procoagulation or/and anti-coagulation conditions
  • 6. The Role of Platelets in Hemostasis Collagen Other factorsTF Thrombin Activated platelet Activated platelet Activated platelet Adhesion Aggregation Contraction Secretion Primary Hemostasis = Activated platelet Activated platelet Activated platelet Activated platelet This plug of activated platelets, localised to the site of injury, provides the phospholipid surface upon which Secondary Hemostasis takes place
  • 7. Coagulation Cascade XII XIIa XI XIa IX VIII VIIIa X Xa Intrinsic Pathway Extrinsic Pathway Endothelial activation or exposure of subendothelium Tissue Factor VIITF/VIIa Kallikrein HMWK Prekallikrein IIaII Ca2+ PL Va V Organized Fibrin/Platelet thrombus Fibrinogen Fibrin Ca2+ PLCa2+ Cross-linked fibrin polymer XIIIa Ca2+ IXa
  • 9. Coagulation Cascade: Regulation • Antithrombin (III) – Regulates activity of all serine proteases – Inhibitory activity enhanced by heparin • Protein C and Protein S – Regulate the activity of co-factors of coagulation Va/VIIIa
  • 10. The Cell-based Model of Coagulation VIIIa IXa + activates various factors APC/PS TFPI Antithrombin
  • 11. What is a Thrombus? Intravascular mass of fibrin and blood cells Arterial thrombi (White thrombi) – High shear rates – Primarily platelet aggregates + fibrin strands Venous Thrombi (Red thrombi) – Low shear rates – Primarily red cells and fibrin strands (few platelets)
  • 12. LDL LDL Mackness MI et al. Biochem J 1993;294:829-834. Endothelium Vessel LumenMonocyte Modified LDL Macrophage MCP-1 Adhesion Molecules Cytokines Pathophysiology of Atherosclerosis Foam Cell HDL Promote Cholesterol Efflux Intima HDL Inhibit Oxidation of LDL
  • 13.
  • 14. Virchow’s thrombosis model Thrombosis Vessel wall injury Slow blood flow (Stasis) Hypercoagulability
  • 15. Injury or Activation of Endothelium • Atherosclerosis – Life style - smoking, obesity • Immune mediated – Heparin induced thrombocytopenia – Antiphospholipid Antibody Syndrome (Lupus Inhib) • Trauma • Artificial Surface (vascular graft) • Inflammation/Infection
  • 16. Abnormal Blood Flow  Decreased mobility  Vessel Obstruction  Eccomomy class syndrome  Pregnancy
  • 17. Risk Factors for Venous Thrombosis Acquired Pregnancy Advancing age Prior thrombosis Immobilization Major surgery Malignancy Estrogens (OCP, HRT< SERMs) APA syndrome Myeloproliferative disorders, IBD HIT Prolonged air travel Inherited Antithrombin Deficiency Protein C deficiency Protein S deficiency Factor V Leiden (FVL) Prothrombin G20210A Dysfibrinogenemias (rare) Mixed/Unknown Homocysteine Factor VIII, IX, XI APC resistance in the absence of FVL Free TFPI PAI-I, PAI-II
  • 18. Site of Thrombosis vs. Coag. Defect Abnormality Arterial Venous Factor V Leiden - + Prothrombin G20210A - + Antithrombin deficiency - + Protein C deficiency - + Protein S deficiency - + Hyperhomocysteinemia + + Lupus Anticoagulant + +
  • 19. Type I (non immune mediated)  The more common form,  May occur in up to 15% of patients receiving therapeutic doses of heparin  Benign and self limiting side effect.  Rarely causes severe thrombocytopenia  Usually doesn't require heparin discontinuation. Heparin induced thrombocytopenia (HIT)
  • 20. Type II (immune type of HIT) Pathogenesis involves the formation of antibodies (usually IgG) against the heparin-platelet factor 4 (PF 4) complex. The HIT Abs trigger procoagulant effect serious arterial and venous thrombosis
  • 21. J Thromb Haem 1,1471, 2003
  • 22. The incidence of HIT is about 3-5% in patients exposed to UFH, the incidence is much lower with the use of LMWH. In patients with de novo exposure to heparin a fall in the platelet count in those with HIT occurs between day 5 and 14.
  • 23. Suspicion • Fall in platelet count by 50% following heparin exposure The clinical spectrum • Isolated HIT • HIT (T), that may be arterial (Stroke, MI, PAD) or venous in nature.
  • 24. Lab diagnosis • Functional assays ---heparin induced platelet aggregation, ---serotonin release assay, • Immunoassays ---Ab to heparin-PF 4 complexes.
  • 25. Treatment Stopping Heparin and Direct thrombin inhibitors Argatorban Platelet transfusion should be avoided Once the platelet count is > 100.000/CC warfarin may be started at low dose.
  • 26. Bilateral foot ischemia secondary to HIT post open heart surgery
  • 27. Bilateral foot ischemia secondary to HIT post open heart surgery
  • 28. Arm ischemia secondary to HIT post open heart surgery

Editor's Notes

  1. Homeostasis:The ability or tendency of an organism or cell to maintain internal equilibrium by adjusting its physiological processes